p53Protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines

Carcinogenesis

Volumn 16, Issue 9, 1995, Pages 2117-2124

  Rämet, Mika ^a   Castrén, Katariina ^a   Järvinen, Kaisu ^a,b   Pekkala, Katja ^a   Turpeenniemi hujanen, Taina ^a,b   Soini, Ylermi ^a   Pääkkö, Paavo ^a   Vähäkangas, Kirsi ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NAPHTHOFLAVONE; BENZO[A]PYRENE; CYTOCHROME P450; MUTANT PROTEIN; POLYCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN INDUCTION; SPECTROFLUOROMETRY;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ADENOCARCINOMA; BENZO(A)PYRENE; BIOTRANSFORMATION; CARCINOGENS, ENVIRONMENTAL; DNA ADDUCTS; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROBLASTS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASMS; OVARIAN NEOPLASMS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028978675     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/16.9.2117     Document Type: Article

References (37)

1. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers Science, 253, 49-53
2. Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 mmour suppressor gene. Nature, 351, 453-456
3. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878
4. Finlay, C.A., Hinds, P.W. and Levine, AJ. (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-1093
5. Chen, P.L., Chen, Y., Bookstein, R. and Lee, W.-H. (1990) Genetic mechanisms of tumor suppression by the human p53 gene. Science, 250, 1576-1580
6. Samow, P., Shih Ho, Y., Williams J. and Levine, A. J. (1982) Adenovirus Elb-58kd tumor antigen and SV40 tumor antigen are physically associated with the same 54kd cellular protein in transformed cells. Cell, 28, 387-394
7. Wemess, B.A., Levine, A.J. and Howley, P.M. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-79
8. Scheffner, M., Wemess, B.A., Huibregtse J.M., Levine, A J. and Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136
9. Farmer, G.E, Bargonetti, J., Zhu, H., Friedman, P., Prywes, R. and Prives, C. (1992) Wild-type p53 activates transcription in vitro. Nature, 358, 83-86
10. Zambetti, G.P., Bargonetti, J., Walker, K., Prives, C. and Levine, AJ. (1992) Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev., 6, 1143-1152
11. EI-Deiry, W.S era. (1994) WAF1/CIP1 induced in p53-mediated G arrest and apoptosis. Cancer Res., 54, 1169-1174
12. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311
13. Fritsche, M., Haessler, C. and Brandner, G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318
14. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16
15. Westra, W.H., OfTerhaus, J.A., Goodman, S.N., Slebos, R.J., Polak, M., Baas, I.O., Rodenhuis, S. and Hruban, R.H. (1993) Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am. J. Surg. Pathol., 17, 213-220
16. Maher, V.M., Patton, J.D., Yang, J.-L., Wang, Y., Yang, L.L., Ausl, A.E., Bhattacharyya, N. and McCormick, J.J. (1987) Mutations and homologous recombination induced in mammalian cells by metabolites of benzo[a]pyrene and 1 -nitropyrene. Environ. Hlth Perspect., 76, 33-39
17. Mazur, M. and Glickman, B.W. (1988) Sequence specificity of mutations induced by benzo[a]pyrene-7, 8-diol-9, 10-epoxide at endogenous aprt gene in CHO cells. Somatic Cell Mol. Genet., 14, 393-400
18. Puisieux, A., Lim, S., Groopman, J. and Ozturk, M. (1991) Selective targetting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res., 51, 6185-6189
19. IARC (1973) Benz.o[a]pyrene. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, International Agency for Research on Cancer, Lyon, France, Vol 3, pp. 91-136
20. VUhakangas, K. and Pelkonen, O. (1989) Host variations in carcinogen metabolism and DNA repair. In Lynch, H.T. and Hirayama, T. (eds). Genetic Epidemiology of Cancer. CRC Press, Boca Raton, FL, pp. 35-54
21. Vhakangas, K., Nevasaari, K., Pelkonen, O. and Kfirki, T. (1979) Effects of various in vitro inhibitors of benzo[a]pyrene metabolism in isolated rat lung perfusions. Acta Pharmacol. Toxicol., 45, 1-8
22. Bjelogrlicjf., Milkinen, M., Slenbiick, F. and VhhUkangas, K. (1994) Beruo a]pyrene-7, 8-diol-9, 10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis, 15, 771-774
23. VShSkangas, K., Haugen, A. and Harris, C.C. (1985) An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrcnc diolepoxide-DNA adducts. Carcinogenesis, 6, 1109-1116
24. Hsu, S.M., Raine, L. and Fanger, H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cvtochem., 29, 577-580
25. Midgley, C.A., Fisher, CJ., Bartek, J., Vojtesek, B., Lane, D. and Bames, D.M. (1992) Analysis of p53 expression in human tumours: An antibody raised against human p53 expressed in Escherichia coli. J. CellSci., 101, 183-189
26. Orita, M., Suzuki, Y., Takao, T. and Hayashi, K. (1989) Rapid and sensitive detection of point mutation and DNA polymorphism using the polymerase chain reaction. Genomics, 5, 874-875
27. Hayashi, K. (1992) PCR-SSCP: A method for detection of mutations. GATA, 9, 73-79
28. Sakai, E. and Tsuchida, N. (1992) Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene, 7, 927-933
29. Lehman, T.A. el al. (1991) p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res., 51, 4090-4096
30. Soussi, T., de Fromental, C. and May, P (1990) Structural aspects of the p53 protein in relation to the gene evolution. Oncogene, 5, 945-952
31. Casey, G., Lo-Hsueh, M., Lopez, M.E, Vogelstein, B. and Stanbridge, E.J. (1991) Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene, 6, 1791-1797
32. Takahashi, K., Sumimoto, H., Suzuki, K. and Ono, T. (1993) Protein synthesis-dependent cytoplasmic translocation of p53 protein after serum stimulation of growth arrested MCF-7 cells. Mol. Carcinogen., 8, 58-66
33. Bischoff, J.R., Friedman, P.N., Marrshak, D.R., Prives, C. and Vogelstein, B (1990) Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl Acad. Sci. USA, 87, 4766-4770
34. Noble, J.R., Willetts, K.E., Mercer, W.E. and Reddel, R.R. (1992) Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53. Exp. Cell Res, 203, 297-304
35. Nelson, W. and Kastan, M. (1994) DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14, 1815-1823
36. Hall, P.A., McKee, P.H., Menage, H.P., Dover, R. and Lane, D.P. (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-207
37. Caamano, J., Ruggen, B., Momiki, S., Sickler, A., Zhang, S.Y. and Klein-Szanto, A.J.P. (1991) Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. Am. J. Pathol., 139, 839-845